In anaplastic thyroid cancer (ATC), MCM5 directly bound to the bromine domain and terminal (BET) protein BRD4 to regulate cell proliferation and may be a new target for ATC therapy [22]. Here, MCM5 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.